BMP6 and ocular melanoma: A similar trend was observed for BMP signaling pathway marker Bone Morphogenetic Protein Receptor Type II (BMPR2) expression, which was significantly higher in control OM than BMP6-treated samples at both time points (Fig. 7D; n = 6, p < 0.0001).